期刊文献+

PEP-1-CAT融合蛋白预处理对过氧化氢诱导的内皮细胞氧化应激损伤的保护作用 被引量:15

The protective effect of PEP-1-CAT fusion protein on hydrogen peroxide.induced oxidative stress injury in human umbilical vein endothelial cells
原文传递
导出
摘要 目的采用体外培养的人脐静脉内皮细胞株(CRL-1730),研究 PEP-1肽介导人过氧化氢酶(CAT)穿透细胞的能力,并探讨 PEP-1-CAT 对过氧化氢(H_2O_2)诱导的内皮细胞氧化应激损伤是否有保护作用。方法构建原核表达质粒 pET15b-PEP-1-CAT,将其在基因工程菌中表达出 N 端带有6个组氨酸“标签”(His-tag)的重组蛋白,并通过金属镍螯合亲和层析对其进行纯化,将纯化得到的PEP-1-CAT 融合蛋白加入体外培养的人脐静脉内皮细胞,通过 Western blot 来分析其转导能力,同时对转导人细胞内的蛋白进行酶活性检测。然后以0.5 mmol/L H_2O_2处理细胞建立内皮细胞氧化应激损伤的模型,检测不同浓度的 PEP-1-CAT 蛋白对氧化应激下细胞存活率、乳酸脱氢酶(LDH)活性及丙二醛(MDA)含量的影响。结果 PEP-1-CAT 融合蛋白能以时间、剂量依赖的方式高效转导进入细胞内。正常内皮细胞 LDH 活性和细胞存活率分别为(540.6±65.7)U/L和100%;H_2O_2处理组 LDH活性显著高[(849.3±95.1)U/L,P<0.01],细胞存活率明显低[(37.23±5.68)%,P<0.01],MDA含量亦较正常组显著高[(8.23±1.58)nmol/L 比(2.46±1.42)nmol/L,P<0.01]。用不同浓度的PEP-1-CAT 对细胞进行预保护,均可显著提高细胞存活率、降低 LDH 释放量,并提高细胞的抗氧化能力,表现为 MDA 含量较 H_2O_2处理组低(P<0.05或<0.01)。结论 PEP-1-CAT 融合蛋白能以天然活性形式高效转导入人脐静脉内皮细胞,且转导的蛋白能有效对抗氧化应激损伤。这种蛋白转导方式,为用 CAT 防治各种与氧化应激损伤有关的疾病提供了一个新的治疗途径。 Objective To investigate the transduction ability of PEP-1-CAT fusion protein into human umbilical vein endothelial cell (HUVECs) and the effects on hydrogen-peroxide (H2O2 )-induced oxidative stress injury in these cells. Methods With the use of TA-cloning program and isocaudamer technique, the pET15b-PEP-1-CAT of prokaryotic expression plasmid was successfully constructed. The recombinant plasmid was transformed into E. coli BL21 ( DE3 ) and the protein expression was induced by IPTG. The recombinant protein has an N-terminal His-tag which could be used to purify the target protein by affinity chromatography on a Ni^2+ -NTA-resin column. The fusion protein PEP-1-CAT was prepared and confirmed by specific enzyme activity in vitro. The purified PEP-1-CAT fusion protein was added on cultured HUVECs in vitro. The transduction ability of PEP-1-CAT fusion protein into cells was analyzed by Western blot and specific enzyme activity. The cells were treated with H2O2 (0. 5 mmol/L) alone and in combination with PEP-1-CAT fusion protein for 4 h. Then, the cell viability, lactate dehydrogenase ( LDH ) and malondialdehyde(MDA) contents were measured. Results The PEP-1-CAT fusion protein could be transduced into the cultured HUVECs in a dose- and time-dependent manner and be stable for at least 48 h. After H2O2 administration, cell viability was significantly reduced compared with control group (37.23% ± 5.68% vs. 100%, P〈0.05) , while LDH leakage (849.3 U/L±95.1 U/L) and MDA (8.23 nmol/L ±1.58 nmol/L) content were significantly higher than that in control group (540. 6 U/L ± 65.7 U/L and 2. 46 nmol/L ± 1.42 nmol/L, respectively, all P 〈 0. 05 ). Preincubation with PEP-1-CAT proteins at various concentrations (0. 25 -2 μmol/L) significantly attenuated H2O2 -induced cell injury. Conclusion The PEP-1-CAT fusion protein could efficiently penetrate HUVECs and the transduced protein could attenuate cellular oxidative stress injury induced by H2O2. The PEP-1-CAT fusion protei
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2006年第10期932-938,共7页 Chinese Journal of Cardiology
关键词 过氧化氢酶 内皮 血管 PEP-1肽 氧化应激 Catalase Endothelium, vascular PEP-1 peptide Oxidative stress
  • 相关文献

参考文献14

  • 1Nelson SK,Bose SK,Grunwald GK,et al.The induction of human superoxide dismutase and catalase in vivo:a fundamentally new approach to antioxidant therapy.Free Radic Biol Med,2006,40:341-347. 被引量:1
  • 2Mates JM.Effects of antioxidant enzymes in the molecular control of reactive oxygen species toxicology.Toxicology,2000,153 (1-3):83-104. 被引量:1
  • 3Halliwell B,Gutteridge JM.Role of free radicals and catalytic metal ions in human disease:an overview.Methods Enzymol,1990,186:1-85. 被引量:1
  • 4姚玲玲,王家宁,黄永章,郭凌郧.利用同尾酶技术构建pET15b-PEP-1-CAT重组质粒[J].郧阳医学院学报,2006,25(1):1-5. 被引量:9
  • 5陈长征 黄华 等.大肠杆菌His6融合表达载体及其产物一步纯化[J].Acta Biochinica et Biophysica Sinica(生物化学与生物物理学报:英文版),1996,28:532-530. 被引量:3
  • 6Bradford MM.A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.Anal Biochem,1976,72:248-254. 被引量:1
  • 7司徒镇强,吴军正主编..细胞培养[M],1996:363.
  • 8Greenwald RA.Superoxide dismutase and catalase as therapeutic agents for human diseases.A critical review.Free Radic Biol Med,1990,8:201-209. 被引量:1
  • 9Verma IM,Somia N.Gene therapy-promises,problems and prospects.Nature,1997,389:239-242. 被引量:1
  • 10Han K,Jeon MJ,Kim KA,et al.Efficient intracellular delivery of GFP by homeodomains of Drosophila Fushi-tarazu and Engrailed proteins.Mol Cells,2000,10:728-732. 被引量:1

二级参考文献11

  • 1丁鹏,王家宁,黄永章,杨波.利用TA克隆载体构建pET15b-SOD1重组质粒[J].郧阳医学院学报,2005,24(2):65-68. 被引量:27
  • 2董晓,王家宁,黄永章,郭凌郧.pET15b-EGFP原核表达载体的构建及其表达和纯化[J].郧阳医学院学报,2005,24(6):321-325. 被引量:19
  • 3Greenwald RA.Superoxide dismutase and catalase as therapeutic agents for human diseases.A critical review[J].Free Radic Biol Med,1990,8(2):201-209. 被引量:1
  • 4Verma IM,Somia N.Gene therapy-promises,problems and prospects[J].Nature,1997,389(6 648):239-242. 被引量:1
  • 5Han K,Jeon MJ,Kim KA,et al.Efficient intracellular delivery of GFP by homeodomains of Drosophila Fushi-tarazu and engrailed proteins[J].Mol Cells,2000,10(6):728-732. 被引量:1
  • 6Yoon HY,Lee SH,Cho SW,et al.Tat-mediated delivery of human glutamate dehydrogenase into PC12 cells[J].Neurochem Int,2002,41(1):37-42. 被引量:1
  • 7Kwon HY,Eum WS,Jang HW,et al.Transduction of Cu,Zn-superoxide dismutase mediated by an HIV-1 Tat protein basic domain into mammalian cells[J].FEBS Lett,2000,485(2-3):163-167. 被引量:1
  • 8Jin LH,Bahn JH,Eum WS,et al.Transduction of human catalase mediated by an HIV-1 TAT protein basic domain and arginine-rich peptides into mammalian cells[J].Free Radic Biol Med,2001,31(11):1 509-1 519. 被引量:1
  • 9Morris MC,Depollier J,Mery J,et al.A peptide carrier for the delivery of biologically active proteins into mammalian cells[J].Nat Biotechnol,2001,19(12):1 173-1 176. 被引量:1
  • 10Zimmermann K,Schogl D,Mannhalter JW.Digestion of terminal restriction endonuclease recognition sites on PCR products[J].Biotechniques,1998,24(4):582-584. 被引量:1

共引文献10

同被引文献98

引证文献15

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部